Dupilumab effectiveness for the treatment of patients with concomitant atopic dermatitis and chronic rhinosinusitis with nasal polyposis

Dupilumab is a totally human monoclonal <em>antibody</em> concentrating on interleukin (<em>IL</em>) Four and <em>IL</em>13 pathways. We carried out a retrospective observational research to guage the efficacy of dupilumab for the therapy of grownup sufferers referred to our Division, from January 2019 to Could 2021, with a analysis of reasonable to extreme AD and concomitant persistent …

Dupilumab effectiveness for the treatment of patients with concomitant atopic dermatitis and chronic rhinosinusitis with nasal polyposisContinue reading